90 related articles for article (PubMed ID: 26261511)
21. MiR-135a biogenesis and regulation in malignancy: a new hope for cancer research and therapy.
Cao Z; Qiu J; Yang G; Liu Y; Luo W; You L; Zheng L; Zhang T
Cancer Biol Med; 2020 Aug; 17(3):569-582. PubMed ID: 32944391
[TBL] [Abstract][Full Text] [Related]
22. CircNOL10 Acts as a Sponge of miR-135a/b-5p in Suppressing Colorectal Cancer Progression via Regulating KLF9.
Zhang Y; Zhang Z; Yi Y; Wang Y; Fu J
Onco Targets Ther; 2020; 13():5165-5176. PubMed ID: 32606737
[TBL] [Abstract][Full Text] [Related]
23. FOXO transcription factor family in cancer and metastasis.
Jiramongkol Y; Lam EW
Cancer Metastasis Rev; 2020 Sep; 39(3):681-709. PubMed ID: 32372224
[TBL] [Abstract][Full Text] [Related]
24. Sulforaphane Induces miR135b-5p and Its Target Gene, RASAL2, thereby Inhibiting the Progression of Pancreatic Cancer.
Yin L; Xiao X; Georgikou C; Luo Y; Liu L; Gladkich J; Gross W; Herr I
Mol Ther Oncolytics; 2019 Sep; 14():74-81. PubMed ID: 31044154
[TBL] [Abstract][Full Text] [Related]
25. miR-135a suppresses migration of gastric cancer cells by targeting TRAF5-mediated NF-κB activation.
Xie Y; Li F; Li Z; Shi Z
Onco Targets Ther; 2019; 12():975-984. PubMed ID: 30774383
[TBL] [Abstract][Full Text] [Related]
26. Insights into the role of endoplasmic reticulum stress in skin function and associated diseases.
Park K; Lee SE; Shin KO; Uchida Y
FEBS J; 2019 Jan; 286(2):413-425. PubMed ID: 30586218
[TBL] [Abstract][Full Text] [Related]
27. Interplay between small and long non-coding RNAs in cutaneous melanoma: a complex jigsaw puzzle with missing pieces.
Riefolo M; Porcellini E; Dika E; Broseghini E; Ferracin M
Mol Oncol; 2019 Jan; 13(1):74-98. PubMed ID: 30499222
[TBL] [Abstract][Full Text] [Related]
28. Tumor-suppressive miRNA-135a inhibits breast cancer cell proliferation by targeting ELK1 and ELK3 oncogenes.
Ahmad A; Zhang W; Wu M; Tan S; Zhu T
Genes Genomics; 2018 Mar; 40(3):243-251. PubMed ID: 29892795
[TBL] [Abstract][Full Text] [Related]
29. miR-135a Confers Resistance to Gefitinib in Non-Small Cell Lung Cancer Cells by Upregulation of RAC1.
Zhang T; Wang N
Oncol Res; 2018 Sep; 26(8):1191-1200. PubMed ID: 29386087
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA-135a regulates NHE9 to inhibit proliferation and migration of glioblastoma cells.
Gomez Zubieta DM; Hamood MA; Beydoun R; Pall AE; Kondapalli KC
Cell Commun Signal; 2017 Dec; 15(1):55. PubMed ID: 29268774
[TBL] [Abstract][Full Text] [Related]
31. Factor VII-Induced MicroRNA-135a Inhibits Autophagy and Is Associated with Poor Prognosis in Hepatocellular Carcinoma.
Huang KT; Kuo IY; Tsai MC; Wu CH; Hsu LW; Chen LY; Kung CP; Cheng YF; Goto S; Chou YW; Chen CL; Lin CC; Chen KD
Mol Ther Nucleic Acids; 2017 Dec; 9():274-283. PubMed ID: 29246306
[TBL] [Abstract][Full Text] [Related]
32. Diagnostic significance and potential function of miR-338-5p in hepatocellular carcinoma: A bioinformatics study with microarray and RNA sequencing data.
Liang L; Gao L; Zou XP; Huang ML; Chen G; Li JJ; Cai XY
Mol Med Rep; 2018 Feb; 17(2):2297-2312. PubMed ID: 29207053
[TBL] [Abstract][Full Text] [Related]
33. An Image-Based miRNA Screen Identifies miRNA-135s As Regulators of CNS Axon Growth and Regeneration by Targeting Krüppel-like Factor 4.
van Battum EY; Verhagen MG; Vangoor VR; Fujita Y; Derijck AAHA; O'Duibhir E; Giuliani G; de Gunst T; Adolfs Y; Lelieveld D; Egan D; Schaapveld RQJ; Yamashita T; Pasterkamp RJ
J Neurosci; 2018 Jan; 38(3):613-630. PubMed ID: 29196317
[TBL] [Abstract][Full Text] [Related]
34. Small Non-coding RNA Abundance in Adrenocortical Carcinoma: A Footprint of a Rare Cancer.
Koduru SV; Leberfinger AN; Ravnic DJ
J Genomics; 2017; 5():99-118. PubMed ID: 28943972
[No Abstract] [Full Text] [Related]
35. BRAF
Lunavat TR; Cheng L; Einarsdottir BO; Olofsson Bagge R; Veppil Muralidharan S; Sharples RA; Lässer C; Gho YS; Hill AF; Nilsson JA; Lötvall J
Proc Natl Acad Sci U S A; 2017 Jul; 114(29):E5930-E5939. PubMed ID: 28684402
[TBL] [Abstract][Full Text] [Related]
36. Reduction of COX-2 through modulating miR-124/SPHK1 axis contributes to the antimetastatic effect of alpinumisoflavone in melanoma.
Gao M; Chang Y; Wang X; Ban C; Zhang F
Am J Transl Res; 2017; 9(3):986-998. PubMed ID: 28386327
[TBL] [Abstract][Full Text] [Related]
37. Effects of miR-145-5p through NRAS on the cell proliferation, apoptosis, migration, and invasion in melanoma by inhibiting MAPK and PI3K/AKT pathways.
Liu S; Gao G; Yan D; Chen X; Yao X; Guo S; Li G; Zhao Y
Cancer Med; 2017 Apr; 6(4):819-833. PubMed ID: 28332309
[TBL] [Abstract][Full Text] [Related]
38. Golgi-Related Proteins GOLPH2 (GP73/GOLM1) and GOLPH3 (GOPP1/MIDAS) in Cutaneous Melanoma: Patterns of Expression and Prognostic Significance.
Donizy P; Kaczorowski M; Biecek P; Halon A; Szkudlarek T; Matkowski R
Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27706081
[TBL] [Abstract][Full Text] [Related]
39. miR-135a Inhibits the Invasion of Cancer Cells via Suppression of ERRα.
Tribollet V; Barenton B; Kroiss A; Vincent S; Zhang L; Forcet C; Cerutti C; Périan S; Allioli N; Samarut J; Vanacker JM
PLoS One; 2016; 11(5):e0156445. PubMed ID: 27227989
[TBL] [Abstract][Full Text] [Related]
40. Posttranscriptional regulation of FOXO expression: microRNAs and beyond.
Urbánek P; Klotz LO
Br J Pharmacol; 2017 Jun; 174(12):1514-1532. PubMed ID: 26920226
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
